Provectus Biopharmaceuticals, Inc. SEC filings PVCT
Provectus Biopharmaceuticals, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jul 28, 2004. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 1, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| D | Filing | Jul 17, 2024 | — |
| D | Filing | Oct 28, 2022 | — |
| D | Filing | Aug 30, 2021 | — |
| DFAN14A | Filing | Apr 21, 2017 | — |
| 25-NSE | Delisting notice | Apr 21, 2017 | — |
| 25-NSE | Delisting notice | Apr 21, 2017 | — |
| PRER14A | Filing | Apr 20, 2017 | — |
| DFAN14A | Filing | Apr 19, 2017 | — |
| NT 10-K | Filing | Mar 16, 2017 | Dec 31, 2016 |
| EFFECT | Filing | Jan 27, 2017 | — |
| CORRESP | Letter to the SEC | Jan 27, 2017 | — |
| CORRESP | Letter to the SEC | Jan 25, 2017 | — |
| CORRESP | Letter to the SEC | Dec 19, 2016 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2016 | — |
| CORRESP | Letter to the SEC | Nov 22, 2016 | — |
| UPLOAD | Letter from the SEC | Nov 16, 2016 | — |
| UPLOAD | Letter from the SEC | Nov 1, 2016 | — |
| CORRESP | Letter to the SEC | Nov 1, 2016 | — |
| UPLOAD | Letter from the SEC | Oct 24, 2016 | — |
| PRER14A | Filing | Oct 21, 2016 | — |
| CORRESP | Letter to the SEC | Oct 20, 2016 | — |
| UPLOAD | Letter from the SEC | Oct 19, 2016 | — |
| SC TO-I/A | Filing | Jul 28, 2016 | — |
| SC TO-I/A | Filing | Jun 28, 2016 | — |
| EFFECT | Filing | May 27, 2016 | — |
| CORRESP | Letter to the SEC | May 25, 2016 | — |
| SC TO-I | Filing | May 13, 2016 | — |
| EFFECT | Filing | May 11, 2016 | — |
| SC TO-I/A | Filing | Mar 31, 2016 | — |
| SC TO-I/A | Filing | Mar 22, 2016 | — |
| NT 10-K | Filing | Mar 16, 2016 | Dec 31, 2015 |
| SC TO-I/A | Filing | Mar 7, 2016 | — |
| SC TO-I/A | Filing | Feb 12, 2016 | — |
| EFFECT | Filing | Jan 15, 2016 | — |
| CORRESP | Letter to the SEC | Jan 13, 2016 | — |
| SC TO-I | Filing | Dec 31, 2015 | — |
| EFFECT | Filing | Jul 27, 2015 | — |
| CORRESP | Letter to the SEC | Jul 23, 2015 | — |
| UPLOAD | Letter from the SEC | Jul 23, 2015 | — |
| CERTNYS | Auto-generated paper document | Jun 19, 2015 | — |
| 8-A12B | Filing | Jun 19, 2015 | — |
| D | Filing | Oct 15, 2014 | — |
| CT ORDER | Filing | Jul 8, 2014 | — |
| CERTNYS | Auto-generated paper document | May 14, 2014 | — |
| 8-A12B | Form 8-a12b | May 13, 2014 | — |
| 8-A12G | Filing | Apr 30, 2014 | — |
| D | Filing | Apr 17, 2014 | — |
| D | Filing | Sep 26, 2013 | — |
| EFFECT | Filing | Apr 15, 2013 | — |
| EFFECT | Filing | Apr 9, 2013 | — |
| EFFECT | Filing | Apr 9, 2013 | — |
| D | Filing | Mar 8, 2013 | — |
| D | Filing | Nov 19, 2012 | — |
| D | Filing | Aug 3, 2012 | — |
| EFFECT | Filing | Jul 20, 2012 | — |
| CORRESP | Letter to the SEC | Jul 17, 2012 | — |
| UPLOAD | Letter from the SEC | Jul 17, 2012 | — |
| CORRESP | Letter to the SEC | Jul 13, 2012 | — |
| UPLOAD | Letter from the SEC | Jul 12, 2012 | — |
| UPLOAD | Letter from the SEC | Jul 10, 2012 | — |
| D | Filing | Mar 22, 2012 | — |
| EFFECT | Filing | Aug 5, 2011 | — |
| UPLOAD | Letter from the SEC | Aug 3, 2011 | — |
| CORRESP | Letter to the SEC | Jul 19, 2011 | — |
| UPLOAD | Letter from the SEC | Jul 6, 2011 | — |
| CORRESP | Letter to the SEC | Jun 28, 2011 | — |
| UPLOAD | Letter from the SEC | Jun 15, 2011 | — |
| CORRESP | Letter to the SEC | May 23, 2011 | — |
| UPLOAD | Letter from the SEC | May 11, 2011 | — |
| D | Filing | May 5, 2011 | — |
| CORRESP | Letter to the SEC | Apr 27, 2011 | — |
| UPLOAD | Letter from the SEC | Apr 14, 2011 | — |
| UPLOAD | Letter from the SEC | Mar 14, 2011 | — |
| CORRESP | Letter to the SEC | Feb 25, 2011 | — |
| CORRESP | Letter to the SEC | Jan 21, 2011 | — |
| UPLOAD | Letter from the SEC | Jan 5, 2011 | — |
| CORRESP | Letter to the SEC | Jan 4, 2011 | — |
| EFFECT | Filing | Aug 5, 2010 | — |
| AW | Pvct aw withdrawal s-3a | Jul 27, 2010 | — |
| EFFECT | Filing | Jul 14, 2010 | — |
| CORRESP | Letter to the SEC | Jul 12, 2010 | — |
| CORRESP | Letter to the SEC | Jul 9, 2010 | — |
| UPLOAD | Letter from the SEC | Jul 2, 2010 | — |
| D | Filing | May 13, 2010 | — |
| D | Filing | Apr 6, 2010 | — |
| D/A | Filing | Mar 26, 2010 | — |
| D | Filing | Mar 24, 2010 | — |
| CT ORDER | Filing | Jan 15, 2010 | — |
| PRER14A | Pvct prer14a revisions | Dec 1, 2009 | — |
| UPLOAD | Letter from the SEC | Nov 17, 2009 | — |
| CORRESP | Letter to the SEC | Nov 2, 2009 | — |
| UPLOAD | Letter from the SEC | Oct 23, 2009 | — |
| CORRESP | Letter to the SEC | Sep 22, 2009 | — |
| UPLOAD | Letter from the SEC | Sep 9, 2009 | — |
| D/A | Filing | Aug 7, 2009 | — |
| D | Filing | Jun 30, 2009 | — |
| EFFECT | Filing | Jun 11, 2009 | — |
| CORRESP | Letter to the SEC | Jun 10, 2009 | — |
| CORRESP | Letter to the SEC | May 26, 2009 | — |
| UPLOAD | Letter from the SEC | May 18, 2009 | — |
| AW | Pvct form aw application for withdrawal | May 5, 2009 | — |
| 10KSB | Pvct 10-ksb 12-31-07 | Mar 20, 2008 | Dec 31, 2007 |
| EFFECT | Filing | Feb 4, 2008 | — |
| CORRESP | Letter to the SEC | Jan 31, 2008 | — |
| CORRESP | Letter to the SEC | Jan 28, 2008 | — |
| SB-2/A | Pvct sb2a2 01-24-08 | Jan 28, 2008 | — |
| CORRESP | Letter to the SEC | Jan 16, 2008 | — |
| UPLOAD | Letter from the SEC | Jan 11, 2008 | — |
| CORRESP | Letter to the SEC | Jan 7, 2008 | — |
| SB-2/A | Pvct sb2/a 01-04-08 | Jan 7, 2008 | — |
| UPLOAD | Letter from the SEC | Dec 13, 2007 | — |
| SB-2 | Pvct sb2 11-30-07 | Dec 3, 2007 | — |
| 10QSB | Pvct 10qsb 09-30-07 | Nov 13, 2007 | Sep 30, 2007 |
| 10QSB | Pvct 10qsb 06-30-07 | Aug 13, 2007 | Jun 30, 2007 |
| REGDEX | Auto-generated paper document | Jun 6, 2007 | — |
| 10QSB | Pvct 10qsb 03-31-07 | May 11, 2007 | Mar 31, 2007 |
| 10KSB | Pvct10ksb123106 | Mar 22, 2007 | Dec 31, 2006 |
| 10QSB | Pvct 10qsb 09-30-06 | Nov 13, 2006 | Sep 30, 2006 |
| REGDEX | Auto-generated paper document | Oct 30, 2006 | — |
| REGDEX | Auto-generated paper document | Oct 4, 2006 | — |
| 10QSB | Pvct 10qsb 06-30-06 | Aug 11, 2006 | Jun 30, 2006 |
| EFFECT | Filing | May 25, 2006 | — |
| SB-2/A | Pvct sb2/a 05-06 | May 24, 2006 | — |
| 10QSB | Pvct 10qsb 05-06 | May 12, 2006 | Mar 31, 2006 |
| SB-2 | Pvct sb2 05-06 | May 11, 2006 | — |
| 10KSB | Pvct 10ksb 12-31-05 | Mar 30, 2006 | Dec 31, 2005 |
| 10QSB | Quarterly report | Nov 14, 2005 | Sep 30, 2005 |
| 10QSB | Quarterly report | Aug 15, 2005 | Jun 30, 2005 |
| 10QSB | Quarterly report on form 10-qsb | May 16, 2005 | Mar 31, 2005 |
| 10KSB | Annual report | Mar 31, 2005 | Dec 31, 2004 |
| REGDEX | Auto-generated paper document | Nov 22, 2004 | — |
| 10QSB | Quarterly report on form 10-qsb | Nov 12, 2004 | Sep 30, 2004 |
| 10KSB/A | Annual report | Nov 1, 2004 | Dec 31, 2003 |
| 10KSB/A | Annual report - amendment no. 2 | Oct 7, 2004 | Dec 31, 2002 |
| 10QSB/A | Quarterly report - amendment no. 1 | Oct 7, 2004 | Mar 31, 2003 |
| 10QSB/A | Quarterly report - amendment no. 1 | Oct 7, 2004 | Jun 30, 2003 |
| 10QSB/A | Quarterly report - amendment no. 1 | Oct 7, 2004 | Sep 30, 2003 |
| 10KSB/A | Annual report - amendment no. 2 | Oct 7, 2004 | Dec 31, 2003 |
| 10QSB/A | Quarterly report - amendment no. 1 | Oct 7, 2004 | Mar 31, 2004 |
| 10QSB/A | Quarterly report - amendment no. 1 | Oct 7, 2004 | Jun 30, 2004 |
| 10QSB | Quarterly financial report | Aug 16, 2004 | Jun 30, 2004 |
| REGDEX | Auto-generated paper document | Aug 11, 2004 | — |
Showing 142 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PVCT (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Knoxville, TN
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 315545
- Former names
- PROVECTUS PHARMACEUTICALS INC (until Dec 18, 2013); PROVECTUS PHARMACEUTICAL INC (until May 15, 2002); ZAMAGE DIGITAL IMAGING INC (until Apr 1, 2002); SPM GROUP INC (until Nov 14, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.